WO2002092613A3 - Acide nucleique se liant a la gnrh - Google Patents
Acide nucleique se liant a la gnrh Download PDFInfo
- Publication number
- WO2002092613A3 WO2002092613A3 PCT/EP2002/005246 EP0205246W WO02092613A3 WO 2002092613 A3 WO2002092613 A3 WO 2002092613A3 EP 0205246 W EP0205246 W EP 0205246W WO 02092613 A3 WO02092613 A3 WO 02092613A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gnrh
- nucleic acid
- nucleic acids
- binds
- target molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1048—SELEX
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2002312906A AU2002312906A1 (en) | 2001-05-11 | 2002-05-13 | Nucleic acid, which binds to gnrh |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10122862.7 | 2001-05-11 | ||
| DE2001122862 DE10122862A1 (de) | 2001-05-11 | 2001-05-11 | GnRH bindende Nukleinsäure |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2002092613A2 WO2002092613A2 (fr) | 2002-11-21 |
| WO2002092613A3 true WO2002092613A3 (fr) | 2003-12-18 |
Family
ID=7684375
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2002/005246 Ceased WO2002092613A2 (fr) | 2001-05-11 | 2002-05-13 | Acide nucleique se liant a la gnrh |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2002312906A1 (fr) |
| DE (1) | DE10122862A1 (fr) |
| WO (1) | WO2002092613A2 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10233704A1 (de) * | 2002-07-24 | 2004-02-12 | Heraeus Noblelight Gmbh | Entladungslampe mit einem rohrförmigen, transparenten Entladungsgefäß sowie deren Verwendung |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998008856A2 (fr) * | 1996-08-30 | 1998-03-05 | Fuerste Jens Peter | Selection et evolution speculaires d'acides nucleiques |
| WO1999044987A1 (fr) * | 1998-03-05 | 1999-09-10 | Agouron Pharmaceuticals, Inc. | AGENTS NON-PEPTIDIQUES ANTI-GnRH |
| WO2001092566A2 (fr) * | 2000-05-26 | 2001-12-06 | Noxxon Pharma Ag | Acides nucleiques immobilises et leur utilisation |
-
2001
- 2001-05-11 DE DE2001122862 patent/DE10122862A1/de not_active Withdrawn
-
2002
- 2002-05-13 WO PCT/EP2002/005246 patent/WO2002092613A2/fr not_active Ceased
- 2002-05-13 AU AU2002312906A patent/AU2002312906A1/en not_active Abandoned
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998008856A2 (fr) * | 1996-08-30 | 1998-03-05 | Fuerste Jens Peter | Selection et evolution speculaires d'acides nucleiques |
| WO1999044987A1 (fr) * | 1998-03-05 | 1999-09-10 | Agouron Pharmaceuticals, Inc. | AGENTS NON-PEPTIDIQUES ANTI-GnRH |
| WO2001092566A2 (fr) * | 2000-05-26 | 2001-12-06 | Noxxon Pharma Ag | Acides nucleiques immobilises et leur utilisation |
Non-Patent Citations (5)
| Title |
|---|
| FAMULOK M ET AL: "Nucleic acid aptamers-from selection in vitro to applications in vivo", ACCOUNTS OF CHEMICAL RESEARCH, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, vol. 33, no. 9, September 2000 (2000-09-01), pages 591 - 599, XP002221277, ISSN: 0001-4842 * |
| LEVA SUSANNE ET AL: "GnRH binding RNA and DNA Spiegelmers: A novel approach toward GnRH antagonism.", CHEMISTRY & BIOLOGY (LONDON), vol. 9, no. 3, March 2002 (2002-03-01), March, 2002, pages 351 - 359, XP002234826, ISSN: 1074-5521 * |
| NOLTE A ET AL: "MIRROR-DESIGN OF L-OLIGONUCLEOTIDE LIGANDS BINDING TO L-ARGININE", NATURE BIOTECHNOLOGY, NATURE PUBLISHING, US, vol. 14, 1 September 1996 (1996-09-01), pages 1116 - 1119, XP002039162, ISSN: 1087-0156 * |
| PATEL D J ET AL: "STRUCTURE, RECOGNITION AND ADAPTIVE BINDING IN RNA APTAMER COMPLEXES", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, vol. 272, 1997, pages 645 - 664, XP002952170, ISSN: 0022-2836 * |
| WILLIAMS KELLY P ET AL: "Bioactive and nuclease-resistant L-DNA ligand of vasopressin", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 94, no. 21, 1997, pages 11285 - 11290, XP002185340, ISSN: 0027-8424 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002312906A1 (en) | 2002-11-25 |
| DE10122862A1 (de) | 2002-11-21 |
| WO2002092613A2 (fr) | 2002-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2003087129A3 (fr) | Peptides immunogenes et methode d'identification desdits peptides | |
| WO2003054511A3 (fr) | Procedes de quantification d'acides nucleiques au moyen de reactions couplees d'amplification et de ligation | |
| WO2002020565A3 (fr) | Groupes de proteines a domaines de repetition comprenant des modules de repetition | |
| WO2003057845A3 (fr) | Systemes et procedes automatises d'analyse de modification post-translationellle proteique | |
| WO2003093472A3 (fr) | Acides nucleiques liant le cgrp | |
| WO2003033732A3 (fr) | Detection en temps reel de produits d'amplification d'adn | |
| WO2003025154A3 (fr) | Procedes et compositions pour la construction et l'utilisation de genotheques de fusion | |
| WO2002038592A3 (fr) | Peptides, leur fabrication et leur utilisation pour la liaison des immunoglobulines | |
| WO2005021786A8 (fr) | Methode de sequençage d'acides nucleiques par ligature d'oligonucleotiques marques | |
| WO2004001418A3 (fr) | Procede de detection et d'extraction d'endotoxines | |
| WO2002024912A3 (fr) | Molécules isolées d'acides nucléiques codant un récepteur d'il-tif/il-22 soluble ou protéine de liaison se liant à l'il-tif/il-22, et leurs utilisations | |
| DE60303020D1 (de) | Verfahren zur gewinnung von nukleinsäuren mit hilfe chaotroper-und ammoniumreagentien | |
| WO2005000862A3 (fr) | Reactifs et procedes pour former des liaisons disulfure et pour glycosyler des proteines | |
| WO2005018552A3 (fr) | Proteines liant l'heparine : capteurs pour la detection de l'heparine | |
| WO2003022868A3 (fr) | Proteines pouvant se lier avec des metaux et procedes associes | |
| WO2002092613A3 (fr) | Acide nucleique se liant a la gnrh | |
| WO2003002730A3 (fr) | Methode de detection de l'activite de la calpaine 3 dans un echantillon biologique et peptides pour la mise en oeuvre de ladite methode | |
| WO2003093434A3 (fr) | Genome nanoarchaeum, polypeptides nanoarchaeum et acides nucleiques les codant et leurs procedes de fabrication et d'utilisation | |
| WO2002083713A3 (fr) | Procede visant les echinocandines | |
| WO2002059322A3 (fr) | Compositions et methodes liees a la famille de genes biosynthetiques de la daptomycine | |
| WO2003014297A3 (fr) | Compositions et procedes relatifs a la famille multigenique biosynthetique de la daptomycine | |
| WO2004013274A3 (fr) | Acides nucleiques a liaison de ghreline | |
| WO2002092612A3 (fr) | Acide nucleique se liant a l'enterotoxine b | |
| WO2001066752A3 (fr) | Genes specifiques de la reproduction | |
| DE69929699D1 (de) | Nukleinsäure, die spezifisch an ein ras zielprotein binden kann |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: JP |
|
| WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |